Clazosentan
CARDIOVASCULAR SYSTEM
Also known as: ACT-108475, AXV-034343, clazosentan sodium, pivlaz, Ro 61-1790, VML 588
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Clazosentan is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2022. DrugCentral lists 2 molecular targets, including EDNRA and EDNRB. Recorded indications include Prevention of cerebrovascular spasm.
- Molecular targets: EDNRA and EDNRB (2 listed in DrugCentral).
- Indications: Prevention of cerebrovascular spasm.
- ATC code: C04AX33 (Other peripheral vasodilators).
- Molecular formula: C25H23N9O6S; molecular weight 577.58 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Prevention of cerebrovascular spasm
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Endothelin-1 receptor | EDNRA | antagonist | Ki 9.89 |
| Endothelin B receptor | EDNRB | unknown | Ki 6.76 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2022-01-20 | PMDA | — | IDORSIA PHARMACEUTICALS JAPAN LTD |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C04AX33 | CARDIOVASCULAR SYSTEM › PERIPHERAL VASODILATORS › PERIPHERAL VASODILATORS › Other peripheral vasodilators |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Clazosentan is on its molecule page.
| Molecular formula | C25H23N9O6S |
|---|---|
| Molecular weight | 577.58 g/mol |
| CAS number | 180384-56-9 |
| InChIKey | LFWCJABOXHSRGC-UHFFFAOYSA-N |
| PubChem CID | 6433095 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Clazosentan used for?
DrugCentral lists the following indications for Clazosentan: Prevention of cerebrovascular spasm.
How does Clazosentan work?
Its molecular targets in DrugCentral include EDNRA (antagonist) and EDNRB.
When was Clazosentan first approved?
Clazosentan was first approved by the PMDA in 2022.
What is the chemical formula of Clazosentan?
Clazosentan has the molecular formula C25H23N9O6S and a molecular weight of 577.58 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5518 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL109648 — compound record and bioactivity
- PubChem CID 6433095 — chemical identifiers
- DrugBank DB06677 — drug record
- FDA UNII 3DRR0X4728 — substance identity
- UniProt P25101 (EDNRA) — target protein
- UniProt P24530 (EDNRB) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.